Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$6.1 - $10.41 $0 - $0
0 New
0 $0
Q1 2024

Apr 30, 2024

BUY
$7.77 - $10.61 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024

BUY
$6.53 - $8.23 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023

BUY
$7.69 - $9.71 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023

BUY
$7.69 - $9.71 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023

BUY
$5.72 - $8.8 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$6.09 - $7.93 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$4.58 - $9.21 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$7.06 - $23.63 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

BUY
$21.6 - $27.79 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

SELL
$23.0 - $29.01 $1,725 - $2,175
-75 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$25.04 - $30.06 $1,577 - $1,893
-63 Reduced 45.65%
75 $2,000
Q2 2021

Aug 13, 2021

BUY
$27.43 - $32.7 $1,069 - $1,275
39 Added 39.39%
138 $4,000
Q1 2021

May 13, 2021

BUY
$21.37 - $34.38 $2,115 - $3,403
99 New
99 $3,000
Q4 2020

Feb 02, 2021

SELL
$15.31 - $21.12 $3,138 - $4,329
-205 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$14.88 - $20.13 $833 - $1,127
56 Added 37.58%
205 $3,000
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $798 - $1,230
60 Added 67.42%
149 $3,000
Q1 2020

May 13, 2020

BUY
$12.98 - $30.25 $1,155 - $2,692
89 New
89 $1,000
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$20.88 - $25.66 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

SELL
$20.52 - $26.45 $2,565 - $3,306
-125 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $2,580 - $3,208
125 New
125 $3,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.99B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.